| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +43.9K | 100% | $0.91 | +$40.1K |
| Sells | 0 | ||||
| Net | +5 | +43.9K | 100% | +$40.1K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David A. Dodd | President, CEO, Director | $39.6K | +$10.8K | +37.5% | Jun 5, 2025 |
| Mark Reynolds | Cfo | $15.1K | +$7.34K | +94.3% | Jun 5, 2025 |
| John N. Spencer Jr | Director | $11.8K | +$15.3K | Oct 17, 2025 | |
| John Sharkey | VP, Business Development | $6.13K | +$5.94K | +3143% | Jun 5, 2025 |
| Kelly T. McKee | Chief Medical Officer | $2.34K | +$742 | +46.4% | Aug 7, 2025 |
| Jayne Morgan | Director | Jun 5, 2025 | |||
| Randal Chase | Director | Jun 5, 2025 | |||
| Nicole Lemerond | Director | Jun 5, 2025 | |||
| Mark Newman | Chief Scientific Officer | Jun 5, 2025 | |||
| Dean Kollintzas | Director | Jun 5, 2025 | |||
| T. Mcnally | Director | Jun 5, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|